Primit Parikh - 09 Dec 2022 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
President and COO
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Issuer symbol
TGAN
Transactions as of
09 Dec 2022
Transactions value $
$0
Form type
4
Filing time
13 Dec 2022, 15:11:57 UTC
Previous filing
01 Dec 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Award $0 +4,655 $0 4,655 09 Dec 2022 Common Stock 4,655 $4.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-twelfth (1/12) of the shares subject to the option will vest in equal monthly installments, subject to the Reporting Person's continued service as of each such vesting date.